India took a much-needed step in the fight against obesity and diabetes with the introduction of Mounjaro (tirzepatide), a ...
Eli Lilly (NYSE:LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass compounding ...
Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...
USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...
Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Tirzepatide was associated with significant reductions in weight primarily due to fat mass loss while preserving lean mass in obesity.
Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback